Marksans Pharma consolidated net profit rises 31.27% in the December 2023 quarter

Sales rise 22.15% to Rs 586.13 crore

Net profit of Marksans Pharma rose 31.27% to Rs 83.24 crore in the quarter ended December 2023 as against Rs 63.41 crore during the previous quarter ended December 2022. Sales rose 22.15% to Rs 586.13 crore in the quarter ended December 2023 as against Rs 479.83 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales586.13479.83 22 OPM %22.6915.97 -PBDT134.6691.94 46 PBT112.6679.20 42 NP83.2463.41 31

Powered by Capital Market - Live News